Dechra Pharmaceuticals PLC Share Price and Company Fundamentals



Price
£2622
Change
98.000 (3.883%)
52 week
31.08 - 5405.0

Last traded: Last Friday at 3:45 PM

Dechra Pharmaceuticals PLC develops, manufactures, regulates, markets, and sells veterinary pharmaceuticals and related products for veterinarians. It operates through three segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. The company offers various endocrinology, dermatology, analgesia and anesthesia, cardiovascular, and critical care products for dogs and cats; water soluble antibiotics, poultry vaccines, and pain management for poultry, pigs, and cattle; and lameness and pain management products for horses and ponies. It also provides pet nutrition products for supporting cats and dogs with various therapeutic conditions, such as allergies, obesity, heart, and kidney diseases. In addition, the company distributes veterinary pharmaceuticals and equipment; offers financial services; markets pet diets; and develops, regulates, manufactures, and markets crop protection. It markets its products through wholesaler and distributor networks. The company operates in the United Kingdom, Germany, rest of Europe, the United States, and internationally. Dechra Pharmaceuticals PLC was incorporated in 1997 and is headquartered in Northwich, the United Kingdom.

Key Metrics

PE ratio

49.10

PB ratio

4.47

Dividend yield

0.02%

Beta

0.61

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—General / Healthcare
Full time employees1998
Websitehttps://www.dechra.com
Mailing address24 Cheshire Avenue Cheshire Business Park Lostock Gralam Northwich CW9 7UA United Kingdom
Phone / Fax44 1606 814730 / 44 1606 814731

Dividends

Dividend yield

0.02%

Dividend amount

£0.45

Payout ratio

77.51%

5Y Avg. yield

1.00%

Dechra Pharmaceuticals PLC paid £0.45 dividend and the ex-dividend date was 27 Oct 2022.The dividend payout ratio is 77.51%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.DPH dividend payout ratio is between 70-90%. The lower dividend payout ratio is preferrable since it provides company margin to grow the dividends in future.

DPH's forward dividend amount is £0.45 and the forward dividend yield is 1.71%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Oct 2022, following are the company executives and directors listed on Dechra Pharmaceuticals PLC.

NameTitleAgeTotal Pay
Mr. Ian D. PageCEO, MD & Exec. Director601.26M
Mr. Paul Nicholas Sandland MAAT, FCCACFO & Exec. Director42790k
Dr. Anthony Gerard GriffinMD of Dechra Veterinary Products for Europe & Exec. Director58601k
Mr. Patrick MeeusGroup Scientific Officer
Ms. Katy CloughGroup HR Director
Mr. Mike EldredPres of North America51
Ms. Melanie HallCompany Sec.

Profitability and management effectiveness

Profit margin

8.54%

Operating margin

14.05%

Return on assets

4.78%

Return on equity

8.96%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Dechra Pharmaceuticals PLC is and its enterprise value is .

The DPH's stocks Beta value is 0.61 making it 39% less volatile compared to LSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Dechra Pharmaceuticals PLC (LSE:DPH) Frequently Asked Questions

1. What is Dechra Pharmaceuticals PLC's Stock Symbol?

Dechra Pharmaceuticals PLC trades on LSE under the ticker symbol "DPH".

2. What is Dechra Pharmaceuticals PLC's stock price today?

One share of DPH stock can currently be purchased for approximately £2622.

3. How can I contact Dechra Pharmaceuticals PLC?

Dechra Pharmaceuticals PLC's mailing address is 24 Cheshire Avenue Cheshire Business Park Lostock Gralam Northwich CW9 7UA United Kingdom. The company can be reached via phone at 44 1606 814730.

4. What is Dechra Pharmaceuticals PLC's official website?

The official website of Dechra Pharmaceuticals PLC is https://www.dechra.com.